Hollsteen
← Lam Research

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $5.4B · 10-Q 0001193125-15-364406 filed Nov 3, 2015Equity incl. NCI · Q2 FY2016: $5.6B · 10-Q 0001628280-16-010687 filed Feb 3, 2016Equity incl. NCI · Q3 FY2016: $5.7B · 10-Q 0000707549-16-000014 filed Apr 25, 2016Equity incl. NCI · Q4 FY2016: $5.9B · 10-K 0000707549-16-000050 filed Aug 17, 2016Equity incl. NCI · Q1 FY2017: $6.2B · 10-Q 0000707549-16-000085 filed Oct 25, 2016Equity incl. NCI · Q2 FY2017: $6.4B · 10-Q 0000707549-17-000010 filed Jan 30, 2017Equity incl. NCI · Q3 FY2017: $6.7B · 10-Q 0000707549-17-000056 filed Apr 24, 2017Equity incl. NCI · Q4 FY2017: $6.8B · 10-K 0000707549-17-000100 filed Aug 15, 2017Equity incl. NCI · Q1 FY2018: $7.3B · 10-Q 0000707549-17-000139 filed Oct 23, 2017Equity incl. NCI · Q2 FY2018: $6.1B · 10-Q 0000707549-18-000016 filed Jan 30, 2018Equity incl. NCI · Q3 FY2018: $6.8B · 10-Q 0000707549-18-000084 filed Apr 24, 2018Equity incl. NCI · Q4 FY2018: $6.5B · 10-K 0000707549-20-000138 filed Aug 18, 2020Equity incl. NCI · Q1 FY2019: $5.3B · 10-Q 0000707549-18-000125 filed Oct 23, 2018Equity incl. NCI · Q2 FY2019: $5.8B · 10-Q 0000707549-19-000008 filed Jan 30, 2019Equity incl. NCI · Q3 FY2019: $5.3B · 10-Q 0000707549-19-000078 filed Apr 30, 2019Equity incl. NCI · Q4 FY2019: $4.7B · 10-K 0000707549-19-000124 filed Aug 20, 2019Equity incl. NCI · Q1 FY2020: $4.9B · 10-Q 0000707549-19-000163 filed Oct 29, 2019Equity incl. NCI · Q2 FY2020: $4.4B · 10-Q 0000707549-20-000020 filed Feb 4, 2020Equity incl. NCI · Q3 FY2020: $4.5B · 10-Q 0000707549-20-000081 filed Apr 28, 2020Equity incl. NCI · Q4 FY2020: $5.2B · 10-K 0000707549-20-000138 filed Aug 18, 2020Equity incl. NCI · Q1 FY2021: $5.4B · 10-Q 0000707549-20-000173 filed Oct 27, 2020Equity incl. NCI · Q2 FY2021: $5.5B · 10-Q 0000707549-21-000017 filed Feb 2, 2021Equity incl. NCI · Q3 FY2021: $5.4B · 10-Q 0000707549-21-000089 filed Apr 28, 2021Equity incl. NCI · Q4 FY2021: $6.0B · 10-K 0000707549-21-000136 filed Aug 17, 2021Equity incl. NCI · Q1 FY2022: $5.8B · 10-Q 0000707549-21-000155 filed Oct 26, 2021Equity incl. NCI · Q2 FY2022: $6.5B · 10-Q 0000707549-22-000012 filed Feb 1, 2022Equity incl. NCI · Q3 FY2022: $6.0B · 10-Q 0000707549-22-000067 filed Apr 26, 2022Equity incl. NCI · Q4 FY2022: $6.3B · 10-K 0000707549-22-000107 filed Aug 24, 2022Equity incl. NCI · Q1 FY2023: $7.4B · 10-Q 0000707549-22-000124 filed Oct 24, 2022Equity incl. NCI · Q2 FY2023: $8.3B · 10-Q 0000707549-23-000008 filed Jan 30, 2023Equity incl. NCI · Q3 FY2023: $8.4B · 10-Q 0000707549-23-000081 filed Apr 24, 2023Equity incl. NCI · Q4 FY2023: $8.2B · 10-K 0000707549-23-000102 filed Aug 15, 2023Equity incl. NCI · Q1 FY2024: $8.0B · 10-Q 0000707549-23-000115 filed Oct 23, 2023Equity incl. NCI · Q2 FY2024: $8.2B · 10-Q 0000707549-24-000016 filed Jan 29, 2024Equity incl. NCI · Q3 FY2024: $8.0B · 10-Q 0000707549-24-000067 filed Apr 29, 2024Equity incl. NCI · Q4 FY2024: $8.5B · 10-K 0000707549-24-000106 filed Aug 29, 2024Equity incl. NCI · Q1 FY2025: $8.5B · 10-Q 0000707549-24-000128 filed Oct 28, 2024Equity incl. NCI · Q2 FY2025: $8.8B · 10-Q 0000707549-25-000014 filed Jan 31, 2025Equity incl. NCI · Q3 FY2025: $9.5B · 10-Q 0000707549-25-000054 filed Apr 25, 2025Equity incl. NCI · Q4 FY2025: $9.9B · 10-K 0000707549-25-000075 filed Aug 11, 2025Equity incl. NCI · Q1 FY2026: $10.2B · 10-Q 0000707549-25-000085 filed Oct 24, 2025Equity incl. NCI · Q2 FY2026: $10.1B · 10-Q 0000707549-26-000009 filed Jan 29, 2026Equity incl. NCI · Q3 FY2026: $10.6B · 10-Q 0000707549-26-000022 filed Apr 23, 2026Equity incl. NCI · Q4 FY2026: $12.5B · 10-K 0000707549-26-000037 filed Aug 7, 20266.812.55.4Q1 FY2016Q4 FY2026Q4 FY2017
$BEquity incl. NCI · Q4 FY2016: $5.9B · 10-K 0000707549-16-000050 filed Aug 17, 2016Equity incl. NCI · Q1 FY2017: $6.2B · 10-Q 0000707549-16-000085 filed Oct 25, 2016Equity incl. NCI · Q2 FY2017: $6.4B · 10-Q 0000707549-17-000010 filed Jan 30, 2017Equity incl. NCI · Q3 FY2017: $6.7B · 10-Q 0000707549-17-000056 filed Apr 24, 2017Equity incl. NCI · Q4 FY2017: $6.8B · 10-K 0000707549-17-000100 filed Aug 15, 2017Equity incl. NCI · Q1 FY2018: $7.3B · 10-Q 0000707549-17-000139 filed Oct 23, 2017Equity incl. NCI · Q2 FY2018: $6.1B · 10-Q 0000707549-18-000016 filed Jan 30, 2018Equity incl. NCI · Q3 FY2018: $6.8B · 10-Q 0000707549-18-000084 filed Apr 24, 20186.86.85.97.3Q4 FY2016Q3 FY2018Q4 FY2017
Q4 FY2017
6.8$B
All values (44)
PeriodValue ($B)Status
Q4 FY202612.5reported
Q3 FY202610.6reported
Q2 FY202610.1reported
Q1 FY202610.2reported
Q4 FY20259.9reported
Q3 FY20259.5reported
Q2 FY20258.8reported
Q1 FY20258.5reported
Q4 FY20248.5reported
Q3 FY20248.0reported
Q2 FY20248.2reported
Q1 FY20248.0reported
Q4 FY20238.2reported
Q3 FY20238.4reported
Q2 FY20238.3reported
Q1 FY20237.4reported
Q4 FY20226.3reported
Q3 FY20226.0reported
Q2 FY20226.5reported
Q1 FY20225.8reported
Q4 FY20216.0reported
Q3 FY20215.4reported
Q2 FY20215.5reported
Q1 FY20215.4reported
Q4 FY20205.2reported
Q3 FY20204.5reported
Q2 FY20204.4reported
Q1 FY20204.9reported
Q4 FY20194.7reported
Q3 FY20195.3reported
Q2 FY20195.8reported
Q1 FY20195.3reported
Q4 FY20186.5reported
Q3 FY20186.8reported
Q2 FY20186.1reported
Q1 FY20187.3reported
Q4 FY20176.8reported
Q3 FY20176.7reported
Q2 FY20176.4reported
Q1 FY20176.2reported
Q4 FY20165.9reported
Q3 FY20165.7reported
Q2 FY20165.6reported
Q1 FY20165.4reported

CSV with all sources · Technical ID: equity_total

More metrics for Lam Research

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$6.8B
Period
Q4 FY2017, ended Jun 25, 2017 · as of Jun 25, 2017 (balance as of date, not a sum)
Source
10-K, filed Aug 15, 2017 · 0000707549-17-000100
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$6.8BAug 15, 201710-K 0000707549-17-000100reported · confidence 1. · current